Merz Aesthetics, Inc., a prominent player in the global aesthetics industry, is headquartered in the United States. Founded in 1908, the company has established itself as a leader in non-surgical aesthetic treatments, focusing on innovative solutions for skin rejuvenation and facial enhancement. With a strong presence in North America, Europe, and Asia, Merz Aesthetics offers a diverse portfolio of products, including dermal fillers and neuromodulators, that are renowned for their quality and efficacy. The company’s flagship products, such as the Belotero® range and Xeomin®, are distinguished by their unique formulations and patient-centric approach. Merz Aesthetics has achieved significant milestones, including numerous awards for product innovation and safety, solidifying its position as a trusted name in aesthetic medicine. With a commitment to advancing aesthetic science, Merz Aesthetics continues to shape the future of beauty and wellness.
How does Merz Aesthetics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Merz Aesthetics, Inc.'s score of 29 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Merz Aesthetics, Inc., headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported figures. The company is a current subsidiary of Merz Pharma GmbH & Co. KGaA, which may influence its climate commitments and initiatives. As of now, Merz Aesthetics has not established any documented reduction targets or climate pledges. The lack of specific emissions data and reduction initiatives suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the context of its parent company, Merz Pharma GmbH & Co. KGaA, it is possible that emissions data and climate commitments could be cascaded from this higher-level organisation. However, no specific details regarding emissions or targets from Merz Pharma have been provided in the current data. In summary, while Merz Aesthetics, Inc. is part of a larger corporate family, it currently lacks specific emissions data and defined climate commitments, indicating a potential area for future development in sustainability practices.
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 2,088,000 | 0,000,000 |
| Scope 2 | 771,000 | 000,000 |
| Scope 3 | 36,782,000 | 00,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Merz Aesthetics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

